Reviewed by Christian Espinosa, MBA, CISSP · Founder & CEO
Published May 2025 · Last reviewed May 2026
The Med Device Cyber Podcast · with Paul-Lukas Hoffschmidt · May 1, 2025 This episode of The Med Device Cyber Podcast features Paul-Lukas Hoffschmidt from Alpha Sophia, who discusses the commercialization challenges and trends in the US MedTech market, with co-host Trevor and host Christian Espinosa. The conversation highlights the increasing importance of the US healthcare market, particularly for European health tech startups. A significant trend identified is the rise of digital health solutions, including AI and software-based medical devices, and combination products. The discussion also touches upon emerging MedTech hubs in the Middle East. A key focus of the episode is the recurring issue of medical device manufacturers delaying cybersecurity considerations until weeks before FDA or MDR submission, leading to costly delays and redesigns. The experts emphasize the importance of baking cybersecurity into the product from the early requirements phase, aligning with FDA guidance. They also delve into the growing awareness among medical device buyers regarding cybersecurity risks and interoperability, often demanding more comprehensive security assurances than regulatory bodies. The episode concludes with advice for MedTech innovators, stressing the long journey of product development and the need to address all potential challenges, including cybersecurity and market fit, as early as possible to avoid expensive retrofits and build trust. This includes developing an omni-channel strategy for market penetration and considering the product's total addressable market.
Key Takeaways
- The US healthcare market is increasingly important for MedTech startups, especially those from Europe, due to its size and slower regulatory processes elsewhere.
- There is a growing trend towards digital health solutions, including AI and software-based medical devices, and combination products comprising both hardware and software.
- Many medical device manufacturers delay cybersecurity considerations until weeks before regulatory submission, resulting in costly delays and product redesigns due to discovered vulnerabilities.
- Cybersecurity should be integrated as a non-functional requirement from the earliest stages of product development, aligning with FDA and MDR guidance.
- Medical device buyers are becoming more aware of cybersecurity risks and interoperability, often requesting more comprehensive security documentation and testing than what is strictly required by regulatory bodies.
- The journey for MedTech innovators is lengthy, often taking six to eight years, and requires early consideration of all challenges, including cybersecurity, regulatory compliance, and market strategy, to avoid expensive delays and build trust.
Listen on mdcpodcast.com · Watch on YouTube
Listen to this episode
Want help applying this to your own device program?
Blue Goat Cyber is a specialist medical device cybersecurity firm: 250+ FDA submissions, zero rejections. If anything in this conversation hit close to home, book a 30-minute strategy session - no cost, no obligation.